Orexo: Zubsolv Rx data
Research Update
2018-10-05
11:27
Zubsolv market share was unchanged in September compared August, and was at 5.1% (Rx) and 5.6% (quantity), according to the latest data from Symphony Health Solutions which was released today.
KP
Klas Palin
Disclosures and disclaimers